President Trump on Thursday night is planning to announce the launch of TrumpRx, the website that he and his aides have touted for months as a platform aimed at lowering prescription drug prices.
The website, which uses technology from health care company GoodRx, is expected to display the cash prices — that is, the prices available when paying without insurance — for certain drugs and direct patients to other sites where they can buy the therapies. It’s part of Trump’s plan to lower drug prices in the U.S., but some experts are skeptical the platform will meaningfully affect affordability.
Though the direct prices are lower than list prices, they still amount to several hundred dollars per month for many drugs, largely more than the cost for patients if they use insurance. And typically when patients buy their drugs directly from pharma companies, none of their spending counts toward their deductibles or out-of-pocket maximums, which are meant to limit costs over time.
Most Popular
